News

Enrico M. Novelli, MD, MS, has been named Director of the University of Maryland School of Medicine (UMSOM) Program in Sickle Cell Disease and a Professor in…

Between 2012 and 2023, sickle cell disease (SCD) mortality increased in Colombia and was significantly higher in socioeconomically disadvantaged regions, according…

Orbital compression syndrome (OCS), also referred to in the sickle cell disease (SCD) literature as orbital infarction syndrome, is an uncommon but potentially…

AbstractSickle cell disease (SCD) is a monogenic hemoglobinopathy in which hemoglobin S (HbS) polymerizes on deoxygenation, leading to sickling of red blood cells (…

AbstractBackground: Sickle cell disease (SCD) is a major cause of morbidity and mortality among children in sub-Saharan African. Hydroxyurea (HU) remains the…

The global Sickle Cell Anemia Testing and Screening Market is expected to experience significant growth over the next decade as healthcare systems worldwide…

India's efforts to develop an effective treatment for the neglected disease sickle cell anaemia have received a significant boost, with Zydus Lifesciences' drug…

Background: Sickle Cell Disease (SCD) causes acute and chronic complications. Hydroxyurea (HU) reduces vaso-occlusive crises (VOCs), and improves patients’ outcomes…

Zydus Lifesciences is advancing its clinical pipeline with permission to start Phase III clinical trials of Desidustat, an oral therapeutic candidate for Sickle…

AbstractSickle cell disease (SCD) is a globally distributed hereditary red cell disorder with still high mortality. Growing evidence indicates that sickle cell…